Masahiro Abe Selected Research

Chemokine CCL4

4/2008	[Mechanisms for formation of myeloma bone disease].
4/2006	[Bone disease in multiple myeloma and its mechanism].
4/2004	Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1alpha and MIP-1beta correlates with lytic bone lesions in patients with multiple myeloma.
9/2002	Role for macrophage inflammatory protein (MIP)-1alpha and MIP-1beta in the development of osteolytic lesions in multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahiro Abe Research Topics

Disease

39	Multiple Myeloma 03/2024 - 09/2002
36	Neoplasms (Cancer) 04/2024 - 02/2004
13	Infections 02/2024 - 03/2004
12	Bone Resorption 09/2021 - 09/2002
8	Bone Diseases (Bone Disease) 05/2023 - 05/2002
7	Fever (Fevers) 03/2023 - 03/2004
6	Hypocalcemia 07/2019 - 01/2013
4	Hyperthermia 01/2024 - 01/2013
4	Lymphoma (Lymphomas) 08/2023 - 12/2004
4	Heart Failure 02/2023 - 05/2007
4	Bacteremia 08/2022 - 01/2016
4	Immunoglobulin Light-chain Amyloidosis 05/2022 - 01/2007
4	Breast Neoplasms (Breast Cancer) 12/2020 - 06/2012
3	Type 2 Diabetes Mellitus (MODY) 11/2023 - 01/2015
3	Neoplasm Metastasis (Metastasis) 10/2023 - 07/2004
3	Pneumonia (Pneumonitis) 02/2023 - 04/2018
3	Osteonecrosis (Kienbock's Disease) 02/2023 - 01/2009
3	Atrial Fibrillation 01/2023 - 01/2015
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2022 - 03/2017
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 06/2011
3	Candidemia 01/2022 - 11/2014
3	Hypersensitivity (Allergy) 01/2022 - 11/2015
3	Inflammation (Inflammations) 01/2022 - 08/2002
3	Lung Neoplasms (Lung Cancer) 06/2020 - 06/2012
3	Pain (Aches) 11/2019 - 07/2002
3	Hypercalcemia (Milk Alkali Syndrome) 01/2019 - 04/2007
3	Atherosclerosis 04/2016 - 01/2011
3	Amyloidosis 01/2016 - 01/2007
3	Infarction (Infarctions) 07/2008 - 05/2005
3	Myocardial Infarction 07/2008 - 11/2003
2	Asthma (Bronchial Asthma) 04/2024 - 01/2023
2	Body Weight (Weight, Body) 04/2024 - 09/2021
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2024 - 01/2019
2	Hypophosphatemia 02/2024 - 06/2023
2	Candidiasis (Moniliasis) 02/2024 - 01/2019
2	Frailty 09/2023 - 01/2022
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2023 - 01/2022
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 01/2021
2	Diabetes Mellitus 01/2023 - 12/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2022 - 08/2007
2	Stomatitis 08/2022 - 01/2016
2	Dysgeusia (Parageusia) 01/2022 - 01/2016
2	Neutropenia 01/2022 - 12/2020
2	Fungemia 01/2022 - 05/2020
2	Rheumatoid Arthritis 01/2022 - 12/2013

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 04/2024 - 02/2002
8	Bortezomib (Velcade)FDA Link 05/2016 - 02/2007
7	Antifungal AgentsIBA 02/2024 - 11/2014
7	Proteins (Proteins, Gene)FDA Link 01/2024 - 02/2002
7	Dexamethasone (Maxidex)FDA LinkGeneric 09/2023 - 08/2007
6	Diphosphonates (Bisphosphonates)IBA 04/2024 - 05/2002
6	CytokinesIBA 01/2017 - 09/2003
5	Proteasome InhibitorsIBA 01/2024 - 08/2007
5	Zoledronic Acid (Zometa)FDA Link 05/2023 - 07/2011
5	Denosumab FDA Link 05/2023 - 01/2013
5	AntigensIBA 01/2021 - 11/2005
5	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 04/2008 - 09/2002
4	Phosphates (Orthophosphate)IBA 02/2024 - 11/2015
4	AcidsIBA 08/2023 - 12/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2004
4	LigandsIBA 04/2020 - 01/2012
4	Thalidomide (Thalomid)FDA Link 06/2009 - 09/2007
4	Chemokine CCL4IBA 04/2008 - 09/2002
4	RANK LigandIBA 04/2008 - 02/2004
3	Lenalidomide (CC 5013)FDA Link 09/2023 - 02/2011
3	Thrombin FDA Link 08/2023 - 12/2017
3	liposomal amphotericin B FDA Link 03/2023 - 01/2018
3	AndrogensIBA 01/2023 - 01/2009
3	Insulin (Novolin)FDA Link 07/2022 - 03/2017
3	Glucose (Dextrose)FDA LinkGeneric 12/2017 - 04/2013
3	CalciumIBA 01/2017 - 12/2007
3	Melphalan (Alkeran)FDA LinkGeneric 01/2016 - 01/2007
2	Interleukin-2 (IL2)IBA 04/2024 - 07/2011
2	Circulating Tumor DNAIBA 03/2024 - 05/2021
2	Fatty Acid-Binding ProteinsIBA 11/2023 - 12/2021
2	Advanced Glycation End ProductsIBA 11/2023 - 01/2015
2	ParaproteinsIBA 09/2023 - 12/2018
2	Heparin Cofactor IIIBA 08/2023 - 12/2021
2	LL Z1640-2IBA 08/2023 - 01/2022
2	Voriconazole (Vfend)FDA LinkGeneric 03/2023 - 01/2022
2	C-Reactive ProteinIBA 03/2023 - 08/2007
2	Rituximab (Mabthera)FDA Link 02/2023 - 10/2017
2	Immunoglobulin G (IgG)IBA 02/2023 - 01/2023
2	Febuxostat FDA Link 01/2023 - 04/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 10/2015
2	Amyloid (Amyloid Fibrils)IBA 05/2022 - 04/2013
2	ParaffinIBA 03/2022 - 01/2012
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 01/2021
2	SteroidsIBA 01/2022 - 05/2018
2	Vincristine (Oncovin)FDA LinkGeneric 01/2022 - 08/2014
2	CreatinineIBA 12/2021 - 01/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 02/2017

Therapy/Procedure

36	Therapeutics 04/2024 - 07/2003
19	Drug Therapy (Chemotherapy) 04/2024 - 03/2004
5	Stem Cell Transplantation 08/2022 - 01/2009
4	Transplantation 02/2024 - 10/2004
3	Hematopoietic Stem Cell Transplantation 03/2022 - 01/2016
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 04/2018 - 09/2004
2	Craniotomy 04/2024 - 03/2023
2	Injections 02/2022 - 03/2017